Form 4: Axogen EVP Marc Began Acquires 22,500 Performance Shares

Axogen's EVP and General Counsel, Marc Began, acquired 22,500 shares of common stock on December 4, 2025, as a result of performance criteria attainment.

Summary

• Marc A. Began, Executive Vice President and General Counsel of Axogen, Inc., acquired 22,500 shares of common stock.
• The transaction date for the acquisition was December 4, 2025.
• These shares were issued at a price of $0, indicating they were an award rather than a purchase.
• The acquisition is a direct result of the attainment of certain performance criteria.
• Following this transaction, Marc Began beneficially owns a total of 40,785 shares of Axogen, Inc. common stock.

Sentiment

Score: 7

Explanation: The filing reports an executive receiving performance-based stock, indicating achievement of company goals and aligning executive interests with shareholders. The future transaction date is notable but explained by performance criteria.

Positives

• The issuance of shares to EVP Marc Began indicates the attainment of specific performance criteria, suggesting positive operational or strategic achievements by the company or the executive.
• The executive's increased ownership aligns his interests further with those of shareholders, potentially fostering long-term value creation.

Negatives

• The issuance of 22,500 shares, while a relatively small amount, represents a minor dilution for existing shareholders.

Future Outlook

NA

Industry Context

This filing reports a routine insider transaction related to executive compensation, which is company-specific and does not directly reflect broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Experience minor dilution from the issuance of new shares, but benefit from increased alignment of executive interests with shareholder value.
• Employees: May perceive this as a positive signal of company performance and executive achievement, potentially boosting morale.

Key Dates

Recommendation

This Form 4 reports a routine executive compensation event where shares were awarded for performance. It does not provide new fundamental information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate for existing investors.

Keywords

Axogen, AXGN, Marc Began, Insider Transaction, Stock Award, Performance Shares, Executive Compensation, Common Stock, SEC Form 4